Literature DB >> 8013591

Local pharmacological manipulation of extracellular dopamine levels in the dorsolateral prefrontal cortex and caudate nucleus in the rhesus monkey: an in vivo microdialysis study.

R C Saunders1, B S Kolachana, D R Weinberger.   

Abstract

The prefrontal cortex, caudate nucleus, and their dopaminergic innervations have been implicated in complex information processing. The present study utilized the in vivo microdialysis technique to characterize the extracellular dopamine levels in the prefrontal cortex and the caudate nucleus in the rhesus monkey. Basal levels of dopamine were consistently found in the caudate nucleus, while levels in the prefrontal cortex were less reliably measured. Manipulation of dopamine levels using tetrodotoxin and high potassium demonstrated that dopamine measured was dependent on neuronal firing. Administration of indirect dopamine agonists d-amphetamine and cocaine into the prefrontal cortex and the caudate nucleus increased extracellular dopamine levels 250% and 5000%, respectively. Amphetamine and cocaine had greater effects on dopamine levels in the caudate than in the prefrontal cortex. Cocaine induced increases appeared to be less than that of amphetamine and the actions of cocaine lasted longer than amphetamine. This study demonstrates the feasibility of using in vivo microdialysis in monitoring neurochemicals in different regions of the rhesus monkey brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013591     DOI: 10.1007/bf00229108

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  21 in total

1.  Magnetic resonance imaging of the rhesus monkey brain: use for stereotactic neurosurgery.

Authors:  R C Saunders; T G Aigner; J A Frank
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

2.  Functional correlates of dopamine neurotransmission.

Authors:  U Ungerstedt; C Pycock
Journal:  Bull Schweiz Akad Med Wiss       Date:  1974-07

3.  In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate.

Authors:  B Moghaddam; C W Berridge; P S Goldman-Rakic; B S Bunney; R H Roth
Journal:  Synapse       Date:  1993-03       Impact factor: 2.562

4.  Dialytrode technology and local profiles of amino acids in the awake cat brain.

Authors:  J M Delgado; J Lerma; R Martín del Río; J M Solís
Journal:  J Neurochem       Date:  1984-05       Impact factor: 5.372

5.  Dialytrode for long term intracerebral perfusion in awake monkeys.

Authors:  J M Delgado; F V DeFeudis; R H Roth; D K Ryugo; B M Mitruka
Journal:  Arch Int Pharmacodyn Ther       Date:  1972

6.  In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis.

Authors:  S Skirboll; J Wang; I Mefford; J Hsiao; K S Bankiewicz
Journal:  Exp Neurol       Date:  1990-11       Impact factor: 5.330

7.  Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum.

Authors:  Y L Hurd; U Ungerstedt
Journal:  Synapse       Date:  1989       Impact factor: 2.562

8.  Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.

Authors:  B H Westerink; M H Tuinte
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

9.  Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects.

Authors:  B H Westerink; J B De Vries
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

10.  Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats.

Authors:  I M Maisonneuve; R W Keller; S D Glick
Journal:  Brain Res       Date:  1990-12-10       Impact factor: 3.252

View more
  8 in total

1.  Overview of microdialysis.

Authors:  T S Shippenberg; A C Thompson
Journal:  Curr Protoc Neurosci       Date:  2001-05

2.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.

Authors:  A Breier; T P Su; R Saunders; R E Carson; B S Kolachana; A de Bartolomeis; D R Weinberger; N Weisenfeld; A K Malhotra; W C Eckelman; D Pickar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

3.  Amphetamine-induced release of dopamine in primate prefrontal cortex and striatum: striking differences in magnitude and timecourse.

Authors:  Hank P Jedema; Rajesh Narendran; Charles W Bradberry
Journal:  J Neurochem       Date:  2014-05-19       Impact factor: 5.372

4.  Overview of brain microdialysis.

Authors:  Vladimir I Chefer; Alexis C Thompson; Agustin Zapata; Toni S Shippenberg
Journal:  Curr Protoc Neurosci       Date:  2009-04

5.  Differential effects of the D- and L- isomers of amphetamine on pharmacological MRI BOLD contrast in the rat.

Authors:  Neil Easton; Fiona Marshall; Kevin C F Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2007-03-27       Impact factor: 4.415

6.  Deprenyl reduces inflammation during acute SIV infection.

Authors:  K M Emanuel; K Runner; Z D Brodnik; B M Morsey; B G Lamberty; H S Johnson; A Acharya; S N Byrareddy; R A España; H S Fox; P J Gaskill
Journal:  iScience       Date:  2022-04-06

7.  Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study.

Authors:  R Narendran; H P Jedema; B J Lopresti; N S Mason; K Gurnsey; J Ruszkiewicz; C-M Chen; L Deuitch; W G Frankle; C W Bradberry
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

8.  Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease.

Authors:  Thomas W Weickert; Venkata S Mattay; Saumitra Das; Llewellyn B Bigelow; Jose A Apud; Michael F Egan; Daniel R Weinberger; Terry E Goldberg
Journal:  Schizophr Res       Date:  2013-07-03       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.